Probiotic-guided CAR-T cells for solid tumor targeting
Science · 13.10.2023 · 382 (6667) · 211-218
DOI: 10.1126/science.add7034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 13.10.2023. Verfasst von Rosa L Vincent und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Probiotics, Escherichia coli. Die Arbeit wurde bisher 277-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
A major challenge facing tumor-antigen targeting therapies such as chimeric antigen receptor (CAR)–T cells is the identification of suitable targets that are specifically and uniformly expressed on heterogeneous solid tumors. By contrast, certain species of bacteria selectively colonize immune-privileged tumor cores and can be engineered as antigen-independent platforms for therapeutic delivery. To bridge these approaches, we developed a platform of probiotic-guided CAR-T cells (ProCARs), in which tumor-colonizing probiotics release synthetic targets that label tumor tissue for CAR-mediated lysis in situ. This system demonstrated CAR-T cell activation and antigen-agnostic cell lysis that was safe and effective in multiple xenograft and syngeneic models of human and mouse cancers. We further engineered multifunctional probiotics that co-release chemokines to enhance CAR-T cell recruitment and therapeutic response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
- Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.
- Data Science Institute, Columbia University, New York, NY 10027, USA.
ORCID-Profile: Rosa L Vincent, Candice R Gurbatri, Courtney Coker, Jongwon Im, Edward R Ballister, Mathieu Rouanne, Thomas Savage, Kenia de Los Santos-Alexis, Nicholas Arpaia, Tal Danino
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
- NCATS NIH HHS
Zitieren
APA
Vincent, R. L., Gurbatri, C. R., Li, F., Vardoshvili, A., Coker, C., Im, J., Ballister, E. R., Rouanne, M., Savage, T., de Los Santos-Alexis, K., Redenti, A., Brockmann, L., Komaranchath, M., Arpaia, N., & Danino, T. (2023). Probiotic-guided CAR-T cells for solid tumor targeting. Science, 382(6667), 211-218. https://doi.org/10.1126/science.add7034
Vancouver
Vincent RL, Gurbatri CR, Li F, Vardoshvili A, Coker C, Im J, et al. Probiotic-guided CAR-T cells for solid tumor targeting. Science. 2023;382(6667):211-218. doi:10.1126/science.add7034
BibTeX
@article{Vincent2023,
author = {Vincent, Rosa L and Gurbatri, Candice R and Li, Fangda and Vardoshvili, Ana and Coker, Courtney and Im, Jongwon and Ballister, Edward R and Rouanne, Mathieu and Savage, Thomas and de Los Santos-Alexis, Kenia and Redenti, Andrew and Brockmann, Leonie and Komaranchath, Meghna and Arpaia, Nicholas and Danino, Tal},
title = {Probiotic-guided CAR-T cells for solid tumor targeting},
journal = {Science},
year = {2023},
volume = {382},
number = {6667},
pages = {211--218},
doi = {10.1126/science.add7034}
}
EUVIMED